Skip to content
TrialScanner

NCT05466890

Phase 2a to Evaluate PL-8177 in Subjects with Active Ulcerative Colitis (UC)

Phase 2Active, not recruitingPTNLead

Registry record

Lead sponsor
Palatin Technologies, Inc
Conditions
Ulcerative Colitis; Ulcerative Colitis Acute; Ulcerative; Ulcerative Colitis Flare
Primary completion
Feb 10, 2025Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT05466890 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT05466890: Phase 2a to Evaluate PL-8177... | TrialScanner